Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Crystal Pharmatech's CDMO Business Unit - Crystal Formulations Services Successfully Passed EU QP Audit 2024-01-31 21:00
WuXi Biologics Successfully Completes First 1,6000L Manufacturing Run in Ireland 2024-01-31 17:31
WuXi XDC Enters into Partnership with Multitude Therapeutics and HySlink Therapeutics, Novel Linker-Payload Technology Enabling Clients to Accelerate ADC Discovery and Development 2024-01-31 10:43
Synbio Tech's Innovative Probiotic Approach Revitalizes Gut and Vaginal Microbiota in Pregnant Women with Candidiasis 2024-01-31 09:00
GMP cell CDMO I Peace, Inc. obtains accreditation as ISO 17025: 2017 compliant 2024-01-31 05:46
Universe Pharmaceuticals INC Reports Fiscal Year 2023 Financial Results 2024-01-31 05:30
Endogenex Receives IDE Approval to Initiate Pivotal Clinical Study 2024-01-30 22:00
XtalPi Unveils Ailux: A New Chapter in AI-Powered Biologics Discovery 2024-01-30 21:00
Singleron launches the AccuraSCOPE® Single Cell Transcriptome 2024-01-30 18:05
Results of the Phase III INSPIRE Study on Qilu Pharmaceutical's Iruplinalkib Published in the Journal of Thoracic Oncology 2024-01-30 16:45
DP Technology Announces Nomination of Development Candidate, a Potential Best-in-Class Kv1.3 Inhibitor for Immunological Diseases Including IBD and AD 2024-01-30 16:32
Vesicure Therapeutics made notable advancements using exosomes to target KRAS mutation 2024-01-29 21:30
Oricell Announces FDA Clearance of IND Application for OriCAR-017, a novel GPRC5D Targeted CAR-T Cell Therapy Utilizing the Company's Proprietary Platform, for the Treatment of Relapsed/Refractory Multiple Myeloma. 2024-01-29 21:08
Ractigen Therapeutics Enters Strategic Partnership with University Medical Center Utrecht to Drive saRNA Innovation in Neurodevelopmental Disorders 2024-01-29 21:00
Peijia Medical Announces Successful Completion of Patient Enrollment for Pivotal TaurusTrio™ Transcatheter Aortic Regurgitation Clinical Trial 2024-01-29 21:00
Asieris Releases Phase III Clinical Study and Real-World Research Data for APL-1706, a Bladder Cancer Diagnosis and Management Drug, at the 2024 ASCO-GU 2024-01-29 16:17
Inside information made public: Nanoform Announces Important Milestone with Promising Clinical Results for Patient-Centric Nanotechnology-Enhanced Enzalutamide 2024-01-26 20:08
FDA clears RF Medical's MYGEN™ M-3004 and MYOBLATE™ Radiofrequency Ablation System 2024-01-26 15:26
AbbVie Expands Biologics Manufacturing Capacity with a $223 Million Investment in Singapore Manufacturing Site 2024-01-26 08:30
First International Shipment of HANSIZHUANG Launched 2024-01-25 21:41
1 53 54 55 56 57 413